All Comments by Lary Walker
- Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival.
- Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases.
- Seeded Aggregation and Transmissible Proteopathy—Creepy Stuff Not Just for Prions Anymore?
- Does IgG therapy prevent Alzheimer's disease?
- Gamma-secretase inhibition reduces spine density in vivo via an amyloid precursor protein-dependent pathway.
- Traveling Tau—A New Paradigm for Tau- and Other Proteinopathies?
- A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system.
- Driving amyloid toxicity in a yeast model by structural changes: a molecular approach.
- Conformational diversity of wild-type Tau fibrils specified by templated conformation change.
- Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease.
- Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial.
- Effect of infarcts on dementia in the Baltimore longitudinal study of aging.
- Exercise alters the immune profile in Tg2576 Alzheimer mice toward a response coincident with improved cognitive performance and decreased amyloid.
- Participation in dementia research: rates and correlates of capacity to give informed consent.
- A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice.